{"id":"https://openalex.org/W2257944857","doi":"https://doi.org/10.1200/jco.1996.14.5.1504","title":"Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.","display_name":"Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.","publication_year":1996,"publication_date":"1996-05-01","ids":{"openalex":"https://openalex.org/W2257944857","doi":"https://doi.org/10.1200/jco.1996.14.5.1504","mag":"2257944857","pmid":"https://pubmed.ncbi.nlm.nih.gov/8622064"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1996.14.5.1504","doi":"https://doi.org/10.1200/jco.1996.14.5.1504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1996.14.5.1504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034374604","display_name":"Wayne Lee Furman","orcid":"https://orcid.org/0000-0001-7352-3556","observed_orcids":["https://orcid.org/0000-0001-7352-3556"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W L Furman","raw_affiliation_strings":["Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S D Baker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114255298","display_name":"C B Pratt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C B Pratt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113604069","display_name":"Gaston K. Rivera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G K Rivera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034189317","display_name":"William Edward Evans","orcid":"https://orcid.org/0000-0002-9333-5322","observed_orcids":["https://orcid.org/0000-0002-9333-5322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W E Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5043293908","display_name":"Clinton F. Stewart","orcid":"https://orcid.org/0000-0002-1546-9720","observed_orcids":["https://orcid.org/0000-0002-1546-9720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C F Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7939,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.8580843,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"14","issue":"5","first_page":"1504","last_page":"1511"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0706000030040741,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.7440000176429749},{"id":"https://openalex.org/keywords/steady-state-drug-concentration","display_name":"steady-state drug concentration","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5889999866485596},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.6639999747276306},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.9919412136077881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8678879737854004},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7948397397994995},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6329256296157837},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5682843327522278},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43479710817337036},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4320371747016907},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.4103856384754181},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40210777521133423},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33618396520614624},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3329120874404907},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3213196098804474},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1996.14.5.1504","doi":"https://doi.org/10.1200/jco.1996.14.5.1504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1996.14.5.1504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:8622064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8622064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G6976670576","display_name":"LEUKEMIA PROGRAM PROJECT","funder_award_id":"P01CA020180","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904664","display_name":"Cancer Center Support Grant (CCSG)","funder_award_id":"P30CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W305459207","https://openalex.org/W345422806","https://openalex.org/W1506883618","https://openalex.org/W1539572069","https://openalex.org/W1603776666","https://openalex.org/W1672428922","https://openalex.org/W1799661034","https://openalex.org/W1955033393","https://openalex.org/W1966831567","https://openalex.org/W1977313198","https://openalex.org/W1995024307","https://openalex.org/W2012797500","https://openalex.org/W2043703023","https://openalex.org/W2056110230","https://openalex.org/W2066206601","https://openalex.org/W2086470381","https://openalex.org/W2134193067","https://openalex.org/W2165867371","https://openalex.org/W2228985714","https://openalex.org/W2253034646","https://openalex.org/W2257426985","https://openalex.org/W2265594607"],"related_works":["https://openalex.org/W2253034646","https://openalex.org/W1835826547","https://openalex.org/W7095691707","https://openalex.org/W1799661034","https://openalex.org/W2157392358","https://openalex.org/W305459207","https://openalex.org/W1896363289","https://openalex.org/W2092301884","https://openalex.org/W1968522647","https://openalex.org/W2257426985"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2],"the":[3,43,62,173],"maximum-tolerated":[4],"systemic":[5,30],"exposure":[6,31],"(MTSE)":[7],"and":[8,103,115,158,172,190],"exposure-limiting":[9,161],"toxicity":[10],"of":[11,28,81,105,121,138,145,175,226],"continuous":[12,200],"infusion":[13,201],"topotecan":[14,29,36,169,202,227],"in":[15,216],"children":[16],"with":[17],"recurrent":[18],"acute":[19],"leukemia.":[20],"PATIENTS":[21],"AND":[22],"METHODS:":[23],"Patients":[24],"received":[25,118],"escalating":[26],"levels":[27],"as":[32,95,97],"measured":[33,48],"by":[34,49,77],"steady-state":[35],"lactone":[37,170],"concentration":[38],"(Css).":[39],"Samples":[40],"obtained":[41,94],"within":[42,88,142],"first":[44],"24":[45],"hours":[46],"were":[47,93,107,141,194,207],"high-pressure":[50],"liquid":[51],"chromatography":[52],"(HPLC)":[53],"for":[54,71,199],"topotecan.":[55,122],"A":[56,165],"two-compartment":[57],"model":[58],"was":[59,69,86,155,160,177,180,183,203],"fit":[60],"to":[61,128,134,151,212],"data":[63],"using":[64],"a":[65,83,217],"Bayesian":[66],"algorithm.":[67],"Css":[68,124,171,210],"calculated":[70],"each":[72,110],"patient;":[73],"if":[74],"it":[75],"differed":[76],"more":[78],"than":[79],"20%":[80,144],"target,":[82],"new":[84],"dosage":[85],"begun":[87],"6":[89],"hours.":[90],"Follow-up":[91],"concentrations":[92],"well":[96],"serial":[98],"plasma":[99],"samples":[100],"postinfusion.":[101],"Toxicity":[102],"evidence":[104],"activity":[106],"assessed":[108],"after":[109,147],"course.":[111],"RESULTS:":[112],"Thirteen":[113],"boys":[114],"five":[116],"girls":[117],"23":[119,139],"courses":[120,140],"Target":[123],"ranged":[125],"from":[126],"1.0":[127],"5.3":[129,163],"ng/mL":[130],"(topotecan":[131],"doses,":[132],"0.5":[133],"3.3":[135],"mg/m2/d).":[136],"Nineteen":[137],"+/-":[143],"target":[146],"adjustment":[148],"(range,":[149],"77%":[150],"139%).":[152],"The":[153,197],"MTSE":[154,198],"4.0":[156,204],"ng/mL,":[157],"mucositis":[159,176],"at":[162,209],"ng/mL.":[164,205],"significant":[166],"relation":[167],"between":[168],"severity":[174],"observed.":[178],"Myelosuppression":[179],"experienced":[181],"but":[182],"not":[184],"considered":[185],"exposure-limiting.":[186],"One":[187],"complete":[188],"response":[189,193],"one":[191],"partial":[192],"noted.":[195],"CONCLUSION:":[196],"Responses":[206],"noted":[208],"comparable":[211],"those":[213],"producing":[214],"responses":[215],"severe":[218],"combined":[219],"immunodeficiency":[220],"(SCID)":[221],"mouse":[222],"model.":[223],"Further":[224],"studies":[225],"are":[228],"warranted.":[229]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}